Examination Report |
1 | TM-1 | 17 Jan 2017 |
2 | Reply to Exam Report (MIS-R) | 25 Feb 2017 |
3 | General Power of Attorney | 01 Mar 2017 |
4 | Letter | 18 Aug 2018 |
5 | Documents in support of Show cause Hearing (SCH) | 22 Mar 2019 |
6 | Journal Copy | 30 Oct 2019 |
7 | TM-O(NOTICE OF OPPOSITION) | 21 Dec 2019 |
8 | TM-O(NOTICE OF OPPOSITION) | 31 Dec 2019 |
1 | Hearing Notice (Show Cause) | 7784139 | 3769854 | 13 Feb 2019 |
2 | Hearing notice (Adjourned) | 8427955 | 4189016 | 14 Jun 2019 |
3 | Tribunal Accepted Notice for : 3460171 | 8798785 | 4337970 | 21 Aug 2019 |
4 | Opposition Notice | 9511090 | 4678806 | 02 Jan 2020 |
5 | Opposition Counter Statement | 10614450 | 4999418 | 29 Oct 2020 |
The application for Nimotil was made on 17 January 2017.
The trademark applicant for Nimotil is CUROSIS HEALTHCARE.
Nimotil is applied in class(es) 5.
Application for Nimotil is on Opposed stage.
Application Id allotted to Nimotil is 3460171.
Trademark agent or attorney for the application is G. D. Bansal & Associates.
Nimotil filed with the Intellectual property office as a WORD.